Screener
Sarepta Therapeutics, Inc. SRPT Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Sarepta Therapeutics, Inc.’s 10-K, filed March 2, 2026.
- Filed
- Mar 2, 2026, 7:02 AM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-084144
| Thereafter | 207,152 | |
| Total minimum lease payments | 340,315 | |
| Less: imputed interest and tenant incentive reimbursable by lessors | (129,741) | |
| Total operating lease liabilities | $ | $210,574 |
| Included in the consolidated balance sheets: | ||
| Current portion of lease liabilities within other current liabilities | $ | $11,196 |
| Lease liabilities, non-current | 199,378 | |
| Total operating lease liabilities | $ | $210,574 |
Item 16. Form 10-K Summary.
FAQ
- What is Sarepta Therapeutics, Inc.'s operating lease liabilities (current)?
- Sarepta Therapeutics, Inc. (SRPT) reported operating lease liabilities (current) of $11.2M in Q4 2025.
- How has Sarepta Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
- Sarepta Therapeutics, Inc.'s operating lease liabilities (current) decreased by 15.6% year-over-year, from $13.27M to $11.2M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s operating lease liabilities (current) has grown at a -11.8% compound annual growth rate (CAGR), from $20.93M to $11.2M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Sarepta Therapeutics, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude